RESPONSE WITHIN 1 BUSINESS DAY

Let's talk.

Tell us about your product, target markets, and timeline. PharmaRevix will respond within 1 business day with the right next step.

30 min

Free call

<1 day

Reply time

RA+PV

Specialists

Start the conversation

Send us a message.

Full name Work email

Company Country

What can we help with? Tell us a bit about your project I agree that PharmaRevix may use this information to respond to my inquiry. I understand this form is for business inquiries only.

Where we work —
and how we reach further.

Headquartered in India, with offices in the UK and Poland, and partner reach in the UAE and Australia — PharmaRevix supports submissions and pharmacovigilance across UK, EU, MENA, APAC, and ROW markets.

India Headquarters

New Delhi · M-4 Swastik Bhawan

United Kingdom

Harrow · 5 Jardine House

Poland

Kraków · Szlak 77/222

Partner Presence:

UAE Australia

View our global presence

India HQ

Poland

UAE

Australia

Office

Partner

FAQ

Common questions before a call.

Yes. PharmaRevix can support standalone QPPV and Deputy QPPV cover, or combine it with PSMF maintenance, ICSR processing, literature screening, aggregate reporting, and signal management.

PharmaRevix can advise on virtual MAH models and support MAH-related regulatory and pharmacovigilance obligations through the right engagement structure.

Most engagements start after a short discovery and scope confirmation. For defined remediation or deadline-driven work, PharmaRevix can prioritize rapid review and a focused action plan.

Yes. PharmaRevix supports pharmaceutical, biotech, medical device, and IVD companies across regulatory affairs, pharmacovigilance, and materiovigilance.